Skip to main content
. 2013 Apr 11;11(2):54–65. doi: 10.3121/cmr.2013.1113

Table 1.

Sample characteristics for those patients with a single condition and one medication, and for the total population.

Patients with One Condition (N=15334)
n (%)
Total Patients (N=31636)
n (%)
Female 9319 (60.8) 18955 (59.9)
 Race/ethnicity
 White 12673(82.7) 26321 (83.2)
 Black 867 (5.7) 1895 (6.0)
 Asian 421 (2.8) 886 (2.8)
 Hispanic 252 (1.6) 484 (1.5)
 American Indian 89 (0.6) 230 (0.7)
 Other 104 (0.7) 230 (0.7)
 No answer 928 (6.1) 1590 (5.0)
Age (years)
 18–29 823 (5.4) 994 (3.1)
 30–39 1370 (8.9) 1765 (5.6)
 40–49 2457 (16.0) 3814 (12.1)
 50–59 3998 (26.1) 7370 (23.3)
 60–69 3172 (20.7) 7071 (22.4)
 70–79 1858 (12.1) 5541 (17.5)
 80–89 1412 (9.2) 4385 (13.9)
 90+ 244 (1.6) 696 (2.2)
Charlson Comorbid Condition Count
 0 11869 (77.4) 20570 (65.0)
 1 2337 (15.2) 7023 (22.2)
 2 823 (5.4) 2722 (8.6)
 3+ 305 (2.0) 1321 (4.2)
Condition (sum >100%)
 Hypertension 5505 (35.9) 18289 (57.8)
 Depression 4349 (28.4) 8067 (25.5)
 Hyperlipidemia 2744 (17.9) 9986 (31.6)
 Asthma/COPD 1012 (6.6) 2672 (8.4)
 Diabetes 842 (5.5) 4361 (14.6)
 Osteoporosis 551 (3.6) 1756 (5.6)
 Cancer 250 (1.6) 1106 (3.5)
 Multiple Sclerosis 81 (0.5) 117 (0.4)
Number of conditions
 1 15334 (100.0) 20390 (64.5)
 2 0 8075 (25.5)
 3 0 2658 (8.4)
 4 0 463 (1.5)
 5 0 42 (0.1)
 6 0 8 (0.03)
Number of drugs
 1 15334 (100.0) 15429 (48.8)
 2 0 7946 (25.1)
 3 0 4249 (13.4)
 4 0 2228 (7.0)
 5+ 0 1784 (5.6)

COPD, chronic obstructive pulmonary disease